Form 4 for HCA HCA Healthcare
Accepted 2024-07-31 00:00:00 ET · period of report 2024-07-29 · accession 0000950170-24-088748 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-07-31 | 2024-07-29+ | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | S - Sale+OE | $362.13 | -4,851 | 9,454 | -34% | -$1.76M |
| D | 2024-07-31 | 2024-07-29 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | F - Tax | $358.73 | -5,293 | 14.3K | -27% | -$1.90M |
| D | 2024-07-31 | 2024-07-29 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | M - OptEx | $145.24 | +8,280 | 19.6K | +73% | +$1.20M |
| D | 2024-07-31 | 2024-07-29 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | M - OptEx | $0.00 | -8,280 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-29 | S | D | 1,864 | $359.92 | 12,441 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-29 | F | D | 5,293 | $358.73 | 14,305 | D | — | — | |
| 3 | Common | Common Stock | 2024-07-29 | M | A | 8,280 | $145.24 | 19,598 | D | — | — | |
| 4 | Common | Common Stock | 2024-07-31 | S | D | 2,987 | $363.51 | 9,454 | D | — | — | |
| 5 | Derivative | Stock Appreciation Right | 2024-07-29 | M | D | 8,280 | $0.00 | 0 | D | $145.24 · — to 2030-01-29 | 8,280 Common Stock | (F1) The stock appreciation rights vested in four equal annual installments beginning on January 29, 2021. |